Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination
DOI: 10.1016/j.scr.2021.102241
Authors: Ying Huang; Hongchun Wu; Xinglong Han; Jie Wu; Miao Yu; Zhen-Ao Zhao; Zhenya Shen; Shijun Hu; Wei Lei
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human ESC in “E8”. “ESC” should be “unspecified regulation” for “EFNB2”. For ECM, use “Matrigel” at “N/A” “N/A”.
Ideally, “ESC” should express “SOX2”, “POU5F1”, “NANOG” at the end of culture.
Step 2: Primitive streak 1
day 1 ~ 3
culture “adherent” human ESC in “CDM3” for “2” days. “ESC” should be “unspecified regulation” for “EFNB2”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| CHIR90021 | 6.0e-6 | mol/l |
Step 3: mesoderm 1
day 3 ~ 4
culture “adherent” human ESC in “CDM3” for “1” days. “ESC” should be “unspecified regulation” for “EFNB2”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| FGF | 2.5e-5 | g/l |
Step 4: endothelial 1
day 4 ~ 7
culture “adherent” human ESC in “CDM3” for “3” days. “ESC” should be “unspecified regulation” for “EFNB2”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| VEGF | 5.0e-5 | g/l |
| BMP4 | 2.5e-5 | g/l |
Ideally, “EC” should express “EFNB2” at the end of culture.